PCI Biotech Holding ASA (PCIB) — Financial Flexibility Index
PCI Biotech Holding ASA (PCIB) has a Financial Flexibility Index of -0.99x as of June 2025. Free cash flow of Nkr-5.95 Million (operating CF Nkr-6.26 Million minus capex Nkr315.50K) represents -1% of total liabilities (Nkr6.01 Million). Check PCI Biotech Holding ASA (PCIB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PCI Biotech Holding ASA Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for PCI Biotech Holding ASA across 17 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of PCI Biotech Holding ASA.
Annual Financial Flexibility Index for PCI Biotech Holding ASA (2008–2024)
Year-by-year free cash flow to debt coverage for PCI Biotech Holding ASA. Explore cash flow to debt ratio of PCI Biotech Holding ASA to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.77x | Nkr-13.76 Million | Nkr-13.76 Million | Nkr7.76 Million | ▲ +40.7% |
| 2023 | -2.99x | Nkr-14.97 Million | Nkr-14.97 Million | Nkr5.01 Million | ▲ +69.2% |
| 2022 | -9.71x | Nkr-59.04 Million | Nkr-59.04 Million | Nkr6.08 Million | ▼ -217.0% |
| 2021 | -3.06x | Nkr-67.97 Million | Nkr-68.31 Million | Nkr22.19 Million | ▲ +17.1% |
| 2020 | -3.70x | Nkr-73.47 Million | Nkr-77.39 Million | Nkr19.88 Million | ▼ -28.8% |
| 2019 | -2.87x | Nkr-78.07 Million | Nkr-83.47 Million | Nkr27.20 Million | ▼ -91.2% |
| 2018 | -1.50x | Nkr-25.67 Million | Nkr-31.08 Million | Nkr17.10 Million | ▲ +1.2% |
| 2017 | -1.52x | Nkr-25.21 Million | Nkr-30.62 Million | Nkr16.59 Million | ▲ +56.6% |
| 2016 | -3.50x | Nkr-32.62 Million | Nkr-35.69 Million | Nkr9.31 Million | ▼ -29.2% |
| 2015 | -2.71x | Nkr-32.84 Million | Nkr-32.84 Million | Nkr12.12 Million | ▲ +3.6% |
| 2014 | -2.81x | Nkr-31.67 Million | Nkr-31.67 Million | Nkr11.27 Million | ▲ +8.2% |
| 2013 | -3.06x | Nkr-28.59 Million | Nkr-28.59 Million | Nkr9.34 Million | ▼ -6.8% |
| 2012 | -2.87x | Nkr-24.35 Million | Nkr-24.35 Million | Nkr8.49 Million | ▼ -14.9% |
| 2011 | -2.50x | Nkr-19.05 Million | Nkr-19.05 Million | Nkr7.63 Million | ▼ -114.9% |
| 2010 | -1.16x | Nkr-10.59 Million | Nkr-10.59 Million | Nkr9.12 Million | ▲ +55.2% |
| 2009 | -2.59x | Nkr-16.72 Million | Nkr-16.84 Million | Nkr6.45 Million | ▼ -47.2% |
| 2008 | -1.76x | Nkr-9.29 Million | Nkr-9.41 Million | Nkr5.28 Million | — |